UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.977-985

2016

Volltextzugriff (PDF)

FRI0273 Rna sequencing detection of gene dysregulation in epithelial sorted cells from salivary gland tissue reveals interesting pathways involved in sjÖgren’s syndrome pathophysiology

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.675

2018

Volltextzugriff (PDF)

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Annals of the rheumatic diseases, 2021-07, Vol.80 (7), p.930-942

2021

Volltextzugriff (PDF)

SAT0399 Chronic Antigenic Stimulation and Activity of the Disease Are Predictive of Lymphoma Development in Primary SjÖgren Syndrome: A Case Control Study of 64 Cases

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.803-804

2015

Volltextzugriff (PDF)

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Leukemia, 2016-02, Vol.30 (2), p.337-345

2016

Volltextzugriff (PDF)

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Leukemia, 2016-09, Vol.30 (9), p.1963-1963

2016

Volltextzugriff (PDF)

O017 Il-7 in primary sjÖgren syndrome (PSS) is secreted by salivary gland epithelial cells after ifn stimulation and is associated with B-cell activation

Annals of the rheumatic diseases, 2018-03, Vol.77 (Suppl 1), p.A9

2018

Volltextzugriff (PDF)

P084 Salivary gland epithelial cells from sjÖgrens’ patients increase B lymphocytes survival and activation

Annals of the rheumatic diseases, 2019-03, Vol.78 (Suppl 1), p.A36

2019

Volltextzugriff (PDF)

Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Annals of the rheumatic diseases, 2016-10, Vol.75 (10), p.1763-1769

2016

Volltextzugriff (PDF)

Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells

Kidney international, 1991-11, Vol.40 (5), p.906-912

1991

Volltextzugriff (PDF)

Évolution des biomarqueurs associés au risque cardiovasculaire sous anti-TNF versus autres biothérapies dans la polyarthrite rhumatoïde: étude ancillaire de l’essai ROC

Revue du rhumatisme (Ed. française : 1993), 2016-11, Vol.83, p.A102-A103

2016

Volltextzugriff (PDF)

In vitro and in vivo effects of UP 269‐6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation

British journal of pharmacology, 1997-02, Vol.120 (3), p.488-494

1997

Volltextzugriff (PDF)

Abcès musculaires aseptiques associés à un syndrome myélodysplasique

La revue de medecine interne, 2013-06, Vol.34, p.A147-A148

2013

Volltextzugriff (PDF)

149 Characterization of novel series of selective PI3Kalpha and PI3Kalpha/mTOR-dual inhibitors

European journal of cancer supplements, 2010, Vol.8 (7), p.53-53

2010

Volltextzugriff (PDF)

115 Discovery and characterization of PI3Kbeta isoform-selective inhibitors

European journal of cancer supplements, 2010, Vol.8 (7), p.43-43

2010

Volltextzugriff (PDF)

The pan phosphoinositide 3-kinase mammalian target of rapamycin inhibitor SAR245409

Leukemia, 2016-09, Vol.30 (9), p.1963

2016

Volltextzugriff (PDF)

Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Leukemia, 2016-09, Vol.30 (9), p.1963-1963

2016

Volltextzugriff (PDF)

In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist

Fundamental & clinical pharmacology, 1995-01, Vol.9 (2), p.119-128

1995

Volltextzugriff (PDF)

Intracellular expression of an antibody fragment-neutralizing p21 Ras promotes tumor regression

Cancer research (Chicago, Ill.), 1998-03, Vol.58 (6), p.1170-1176

1998

Volltextzugriff (PDF)

A structure-based approach to selective PI3Kbeta inihibition

Acta crystallographica. Section A, Foundations of crystallography, 2012-08, Vol.68 (a1), p.s26-s26

2012

Volltextzugriff (PDF)

Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives

European journal of medicinal chemistry, 1995, Vol.30 (5), p.365-375

1995

Volltextzugriff (PDF)

Synthesis and structure-activity relationships of novel benzimidazole and imidazo[4,5-b]pyridine acid derivatives as thromboxane A2 receptor antagonists

Journal of medicinal chemistry, 1993-04, Vol.36 (9), p.1175-1187

1993

Volltextzugriff (PDF)

Synthesis and activities of new arylsulfonamido thromboxane A2 receptor antagonists

European journal of medicinal chemistry, 1993, Vol.28 (7-8), p.625-632

1993

Volltextzugriff (PDF)

Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2

Cancer gene therapy, 2000-05, Vol.7 (5), p.789-798

2000

Volltextzugriff (PDF)

Metastatic phenotype of murine tumor cells expressing different cooperating oncogenes

International journal of cancer, 1992-07, Vol.51 (5), p.798-804

1992

Volltextzugriff (PDF)

1 – 25 von 323

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(227)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Technology
(111)
Engineering
(91)
Engineering, Electrical & Electronic
(80)
Telecommunications
(52)
Antenna Measurements
(49)
Antennas
(42)
Life Sciences & Biomedicine
(42)
Humans
(35)
Antenna Arrays
(34)
Unmanned Aerial Vehicles
(30)
Extraterrestrial Measurements
(28)
Physical Sciences
(27)
Radio Astronomy
(26)
Antenna Radiation Patterns
(25)
Arrays
(24)
Manufacturing
(24)
Prototypes
(24)
Additive Manufacturing
(20)
Apertures
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

FRI0273 Rna sequencing detection of gene dysregulation in epithelial sorted cells from salivary gland tissue reveals interesting pathways involved in sjÖgren’s syndrome pathophysiology

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

SAT0399 Chronic Antigenic Stimulation and Activity of the Disease Are Predictive of Lymphoma Development in Primary SjÖgren Syndrome: A Case Control Study of 64 Cases

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

O017 Il-7 in primary sjÖgren syndrome (PSS) is secreted by salivary gland epithelial cells after ifn stimulation and is associated with B-cell activation

P084 Salivary gland epithelial cells from sjÖgrens’ patients increase B lymphocytes survival and activation

Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells

Évolution des biomarqueurs associés au risque cardiovasculaire sous anti-TNF versus autres biothérapies dans la polyarthrite rhumatoïde: étude ancillaire de l’essai ROC

In vitro and in vivo effects of UP 269‐6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation

Abcès musculaires aseptiques associés à un syndrome myélodysplasique

149 Characterization of novel series of selective PI3Kalpha and PI3Kalpha/mTOR-dual inhibitors

115 Discovery and characterization of PI3Kbeta isoform-selective inhibitors

The pan phosphoinositide 3-kinase mammalian target of rapamycin inhibitor SAR245409

Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist

Intracellular expression of an antibody fragment-neutralizing p21 Ras promotes tumor regression

A structure-based approach to selective PI3Kbeta inihibition

Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives

Synthesis and structure-activity relationships of novel benzimidazole and imidazo[4,5-b]pyridine acid derivatives as thromboxane A2 receptor antagonists

Synthesis and activities of new arylsulfonamido thromboxane A2 receptor antagonists

Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2

Metastatic phenotype of murine tumor cells expressing different cooperating oncogenes

Suchergebnisse filtern